African-American and white caregivers of older adults with dementia: Differences in depressive symptomatology and psychotropic drug use

Journal of the American Geriatrics Society

Volumn 53, Issue 3, 2005, Pages 397-404

  Sleath, Betsy ^a   Thorpe, Joshua ^a   Landerman, Lawrence R ^b,c   Doyle, Marti ^c   Clipp, Elizabeth ^c,d,e  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Antianxiety agents; Antidepressants; Caregivers; Race

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HYPNOTIC AGENT; PSYCHOTROPIC AGENT; SEDATIVE AGENT;

ADULT; AFRICAN AMERICAN; AGED; AGING; ALZHEIMER DISEASE; CAREGIVER; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DISEASE COURSE; DISEASE PREDISPOSITION; DRUG CLASSIFICATION; DRUG USE; EUROPEAN AMERICAN; FEMALE; HUMAN; MALE; MULTIINFARCT DEMENTIA; POPULATION RESEARCH; RACE DIFFERENCE; REVIEW; SOCIAL SUPPORT; SYMPTOMATOLOGY; ARTICLE; CAUCASIAN; DAILY LIFE ACTIVITY; EDUCATIONAL STATUS; FAMILY; PSYCHOLOGICAL ASPECT; STATISTICAL MODEL; UNITED STATES; VETERAN;

ACTIVITIES OF DAILY LIVING; AFRICAN AMERICANS; AGED; ANTIDEPRESSIVE AGENTS; CAREGIVERS; DEMENTIA; DEPRESSION; EDUCATIONAL STATUS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FAMILY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; PSYCHOTROPIC DRUGS; SOCIAL SUPPORT; UNITED STATES; VETERANS;

EID: 17444392458     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2005.53155.x     Document Type: Review

References (44)

1. Alzheimer's Association Statistics: About Alzheimer's Disease (2002) [on-line]. Alzheimer's Association. Available at www.alz.org/ResourceCenter/ Fact-Sheets/FSAlzheimersStats.pdf February 10, 2003.
2. Katzman R. Epidemiology of Alzheimer's disease and dementia: Advances and challenges. In: Iqbal L, Sisodia S, Winblad B, eds. Alzheimer's Disease: Advances in Etiology, Pathogenesis and Therapeutics. Chichester: John Wiley and Sons, Ltd, 2001, pp 11-12.
3. Harwood DG, Barker WW, Cantillon M et al. Depressive symptomatology in first-degree family caregivers of Alzheimer disease patients: A cross-ethnic comparison. Alzheimer Dis Assoc Disord 1998;12:340-346.
4. Knight BG, Silverstein M, McCallum TJ et al. A sociocultural stress and coping model for mental health outcomes among African American caregivers in southern California. J Gerontol B Psychol Sci Soc Sci 2000;55B:P142-P150.
5. Zarit S, Reeves K, Bach-Peterson J. Relatives of the impaired elderly. Correlates of feelings of burden. Gerontologist 1980;20:649-655.
6. Russo J, Vitaliano PP, Brewer DD et al. Psychiatric disorders in spouse caregivers of care-recipients with Alzheimer's disease and matched controls: A diathesis-stress model of psychopathology. J Abnorm Psychol 1995;104:197-204.
7. Baumgarten M, Battista RN, Infante-Rivard C et al. The psychological and physical health of family members caring for an elderly person with dementia. J Clin Epidemiol 1992;45:61-70.
8. Kiecolt-Glaser JK, Dura JR, Speicher CE et al. Spousal caregivers of dementia victims. Longitudinal changes in immunity and health. Psychosomatic Med 1991;53:345-362.
9. Dura J, Stukenberg K, Kiecolt-Glaser J. Anxiety and depressive disorders in adult children caring for demented patients. Psychol Aging 1991;6:467-473.
10. Schulz R, O'Brien ATT, Bookwala J. Psychiatric and physical morbidity effects of dementia caregiving: Prevalence, correlates, and causes. Gerontologist 1995;35:771-791.
11. Zanetti O, Frisoni GB, Bianchetti A et al. Depressive symptoms of Alzheimer caregivers are mainly due to personal rather than patient factors. Int J Geriatr Psychiatry 1998;6:358-367.
12. Haley WE, Roth DL, Goleton MI et al. Appraisal, coping and social support as mediators of well-being in black and white family caregivers of patients with Alzheimer's disease. J Consult Clin Psychol 1996;64:121-129.
13. Connell CM, Gibson GD. Racial, ethnic, and cultural differences in dementia caregiving. Review and analysis. Gerontologist 1997;37:355-364.
14. Melfi CA, Croghan TW, Hanna MP et al. Racial variation in antidepressant treatment in a Medicaid population. J Clin Psychiatry 2000;61:16-21.
15. Wells KB, Kamberg C, Brook R et al. Health status, sociodemographic factors, and the use of prescribed psychotropic drugs. Med Care 1985;23:1295-1306.
16. Wells KB, Goldberg G, Brooks R et al. Management of patients on psychotropic drugs in primary care clinics, Med Care 1988;26:645-657.
17. Clipp EC, George LK. Psychotropic drug use among caregivers of patients with dementia. J Am Geriatr Soc 1990;38:227-235.
18. Landerman R, George LK, Campbell RT et al. Alternative models of the stress buffering hypothesis. Am J Community Psychol 1989;17:625-642.
19. Koenig HG, Cohen HJ, Blazer DG et al. Profile of depressive symptoms in younger and older medical inpatients with major depression. J Am Geriatr Soc 1993;41:1169-1176.
20. Fillenbaum G. Multidimensional Functional Assessment of Older Adults. Hillsdale: Lawrence Erlbaum Associates, 1988.
21. Radloff L. The CES-D Scale. A self-report depression scale for research in the general Population. Appl Psychol Meas 1977;1:385-410.
22. Blazer D, Burchett B, Service C et al. The association of age and depression among the elderly: An epidemiologic exploration. J Gerontol 1991;46:M210-M215.
23. Hays JC, Blazer DG, Gold DT et al. CES-D: Cutpoint or changes score? J Am Geriatr Soc 1993;41:344-347.
24. Tariot PN, Mack JL, Patterson MB et al. The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. Am J Psychiatry 1995;152:1349-1357.
25. Mack JL Patterson MB. Manual: CERAD Behavior Rating Scale for Dementia, 2nd Ed. Durham: Consortium to Establish a Registry for Alzheimer's Disease, 1996.
26. Anderson R, Newman J. Societal and individual determinants of medical care utilization in the United States. Milbank Mem Fund Q 1973;51:95-124.
27. Hahn BA. Children's health. Racial and Ethnic differences in the use of prescription medications. Pediatrics 1995;95:727-732.
28. Bush PJ, Osterweis M. Pathways to medicine use. J Health Soc Behav 1978; 19:179-189.
29. Aparasu RR, Mort JR, Brandt H. Psychotropic prescription use by community-dwelling elderly in the United States. J Am Geriatr Soc 2003;51:671-677.
30. Smith SR, Kirking DM. Access and use of medications in HIV disease. Health Serv Res 1999;34:123-144.
31. Gray SL, Hanlon J, Fillenbaum GG et al. Predictors of nutritional supplement use by the elderly. Pharmacotherapy 1996;16:715-720.
32. Corbie-Smith G, Thomas SB, St George DM. Distrust, race, and research. Arch Intern Med 2002;162:2458-2463.
33. Cooper LA, Gonzales JJ, Gallo JJ et al. The acceptability of treatment for depression among African-American, Hispanic, and white primary care patients. Med Care 2003;41:479-489.
34. Lupton D. Consumerism, reflexivity, and the medical encounter. Soc Sci Med 1997;45:373-381.
35. Thompson SC, Pitts JS, Schwankovsky L. Preferences for involvement in medical decision-making: Situational and demographic influences. Patient Educ Couns 1993;22:133-140.
36. Sleath BL, Wurst K, Lowery T. Drug information sources and antidepressant adherence. Community Ment Health J 2003;39:359-368.
37. Kroenke K, Spitzer RL. The PHQ-9: A new depression diagnostic and severity measure. Psychiatr Ann 2002;32:509-515.
38. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: The PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999; 28:1737-1744.
39. Swartz M, Landerman R, George LK et al. Benzodiazepine anti-anxiety agents. Prevalence and correlates of use in a southern community. Am J Public Health 1991;81:592-596.
40. American Psychiatric Association practice guideline for the treatment of patients with major depressive disorder. Am J Psychiatry 2000;157(4 Suppl):l-45.
41. Blazer D, Hybels CF, Simonsick EM et al. Marked differences in antidepressant use by race in an elderly community sample: 1986-96. Am J Psychiatry 2000;157:1089-1094.
42. Blazer D, Hybels C, Simonsick E et al. Sedative, hypnotic, and antianxiety medication use in an aging cohort over ten years: A racial comparison, J Am Geriatr Soc 2000;48:1073-1079.
43. Cooper LA, Brown C, Vu HT et al. How important is intrinsic spirituality in depression care? A comparison of white and African-American primary care patients. J Gen Intern Med 2001;16:634-638.
44. Cooper-Patrick L, Powe NR, Jenckes ML et al. Identification of patient attitudes and preferences regarding treatment of depression. J Gen Intern Med 1997;12:431-438.